CD69+CD103− CD4+ TRM cells were the major source of interleukin-17A (IL-17A) production in the colon and TIGIT deficiency protected mice from induction of experimental colitis by reducing IL-17A–producing CD69+CD103− CD4+ TRM cells. This evidence concerns the gene TIGIT and colitis.